HRTX Disposition Disclosure
Collard Craig A · SEC Form 4 · Filed Oct 21, 2026
Disposition
Calculated transaction value
$1.21K
Collard Craig A Chief Executive Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Oct 19, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed 2 days later
HRTX daily price context
Close on/before transaction
$0.36
Oct 19, 2026
First close after public filing
$0.34
Oct 21, 2026
Return after filing · so far
+10.6%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,360 shares @ $0.36
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0001193125-26-427524
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.21K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 19, 2026 | Not reported |
| Heron Therapeutics, Inc. /de/ HRTX | Exercise | Oct 19, 2026 | $0 |
| Heron Therapeutics, Inc. /de/ HRTX Current | Disposition | Oct 19, 2026 | $1.21K |